U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07496918) titled 'Brain Effects of Gamma Frequency Sensory Stimulation (40Hz Light, Sound and Other Devices)' on Jan. 09, 2025.
Brief Summary: Despite the huge healthcare and economic impact of AD, there is still no disease modifying therapeutics available. In fact, the available therapeutics show low efficacy at best in the treatment of cognitive impairment in dementia. Development of a non-invasive medical device that is effective in slowing cognitive impairment is not only revolutionary but also possibly cost- effective. In this study, participants will come to MIT for a 1-day visit and the investigators will evaluate the effects of GENUS in cogn...